ZA963584B - Nanoparticles for oral administration of pharmaceutical agents of low solubility - Google Patents

Nanoparticles for oral administration of pharmaceutical agents of low solubility

Info

Publication number
ZA963584B
ZA963584B ZA963584A ZA963584A ZA963584B ZA 963584 B ZA963584 B ZA 963584B ZA 963584 A ZA963584 A ZA 963584A ZA 963584 A ZA963584 A ZA 963584A ZA 963584 B ZA963584 B ZA 963584B
Authority
ZA
South Africa
Prior art keywords
nanoparticles
oral administration
pharmaceutical agents
low solubility
solubility
Prior art date
Application number
ZA963584A
Other languages
English (en)
Inventor
Robert Gurny
Eric Olivier Allemann
Jean-Christophe Le Roux
Original Assignee
Ciba Geigy
Robert Gurny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy, Robert Gurny filed Critical Ciba Geigy
Publication of ZA963584B publication Critical patent/ZA963584B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA963584A 1995-05-08 1996-05-07 Nanoparticles for oral administration of pharmaceutical agents of low solubility ZA963584B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95810306 1995-05-08

Publications (1)

Publication Number Publication Date
ZA963584B true ZA963584B (en) 1996-11-08

Family

ID=8221740

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA963584A ZA963584B (en) 1995-05-08 1996-05-07 Nanoparticles for oral administration of pharmaceutical agents of low solubility

Country Status (13)

Country Link
EP (1) EP0835103B1 (xx)
JP (1) JP4128621B2 (xx)
AR (1) AR002049A1 (xx)
AT (1) ATE297195T1 (xx)
AU (1) AU5811996A (xx)
CA (1) CA2219777C (xx)
DE (1) DE69634818T2 (xx)
ES (1) ES2243952T3 (xx)
IL (1) IL118162A (xx)
PT (1) PT835103E (xx)
TW (1) TW493991B (xx)
WO (1) WO1996035414A1 (xx)
ZA (1) ZA963584B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045829A (en) * 1997-02-13 2000-04-04 Elan Pharma International Limited Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
FR2766368B1 (fr) * 1997-07-24 2000-03-31 Univ Claude Bernard Lyon Procede de preparation de nanocapsules de type vesiculaire, utilisables notamment comme vecteurs colloidaux de principes actifs pharmaceutiques ou autres
EP0901786B1 (en) 1997-08-11 2007-06-13 Pfizer Products Inc. Solid pharmaceutical dispersions with enhanced bioavailability
US6350786B1 (en) 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
SA99191255B1 (ar) 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
DE60124080T2 (de) * 2000-03-23 2007-03-01 Elan Pharmaceuticals, Inc., San Francisco Verbindungen und verfahren zur behandlung der alzheimerschen krankheit
GB0216700D0 (en) 2002-07-18 2002-08-28 Astrazeneca Ab Process
GB0302673D0 (en) 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
ATE544447T1 (de) 2003-09-26 2012-02-15 Alza Corp Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
EP1923051A4 (en) * 2005-09-06 2012-12-19 Astellas Pharma Inc MICROPARTICLES OF A HEAVY-DUTY SUBSTANCE WITH ENTERIAN BASE MATERIAL ADSORBED ON THE SUBSTANCE SURFACE
US20090004231A1 (en) 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
TW200946266A (en) * 2008-02-27 2009-11-16 Kuraray Co Method of manufacturing metalnanowire and dispersion medium comprising the resultant metalnanowire, and transparent conductive film
WO2010084088A2 (en) 2009-01-21 2010-07-29 Basf Se Starch nanoparticles for drug delivery systems
WO2010084060A1 (en) 2009-01-21 2010-07-29 Basf Se Starch copolymers and nanoparticles thereof for drug delivery systems
GB201006038D0 (en) 2010-04-12 2010-05-26 Unilever Plc Improvements relating to antiviral compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
US5382435A (en) * 1993-03-24 1995-01-17 Southwest Research Institute Microparticulate pharmaceutical delivery system

Also Published As

Publication number Publication date
JP4128621B2 (ja) 2008-07-30
DE69634818T2 (de) 2006-03-23
AR002049A1 (es) 1998-01-07
CA2219777C (en) 2007-06-12
DE69634818D1 (de) 2005-07-14
EP0835103A1 (en) 1998-04-15
WO1996035414A1 (en) 1996-11-14
IL118162A0 (en) 1996-09-12
AU5811996A (en) 1996-11-29
ES2243952T3 (es) 2005-12-01
ATE297195T1 (de) 2005-06-15
JPH11504638A (ja) 1999-04-27
CA2219777A1 (en) 1996-11-14
TW493991B (en) 2002-07-11
EP0835103B1 (en) 2005-06-08
PT835103E (pt) 2005-10-31
IL118162A (en) 2001-10-31

Similar Documents

Publication Publication Date Title
IL115097A0 (en) Pharmaceutical compositions adapted for oral administration
IL118637A (en) Oral pharmaceutical compositions of s(+)-ibuprofen
ZA982609B (en) Pharmaceutical composition for the oral administration of an n-piperidinopyrazole-e-carboxamide derivative its salts and their solvates
PL322579A1 (en) 2-methyl-thiene-benzodiazeoin prparation for oral administration
HUP9903734A3 (en) Controlled-release pharmaceutical formulations for oral administration and method for preparing this
IL117041A0 (en) Oral pharmaceutical dosage form
HUP0004050A3 (en) Itraconazole exhibiting improved solubility, a method of preparing the same and pharmaceutical composition for oral administration comprising the same
IL118162A0 (en) Nanoparticles for oral administration of pharmaceutical agents of low solubility
HUP9900751A3 (en) Stable pharmaceutical forms of administration containing parathormone
PL314732A1 (en) S(+)-ethodolac preparations for oral administration
PL332249A1 (en) Pharmaceutical microspheres of varproinic acid for oral administration
AU4478496A (en) Extended-release solid oral dosage forms of drugs having low solubility in water
HU9402785D0 (en) Paramycin formulations for oral administration
IL112745A0 (en) Formulations for orally administered pharmaceutical agents
IL114673A (en) Pharmaceutical compositions containing protein for oral administration
EP0953359A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
HUP9904320A3 (en) Pharmaceutical compositions of weak acid drugs for colonic delivery
IL118411A0 (en) 2-Substituted benzimidazole derivatives and pharmaceutical compositions containing them
AU3860797A (en) Pharmaceutical formulations for oral administration
PL325509A1 (en) Therapeutic agent for oral administration
IL118412A0 (en) 2-Substituted benzimidazole derivatives and pharmaceutical compositions containing them
GB9504969D0 (en) Oral administration of proteinaceous drugs
HUP0101012A3 (en) Pharmaceutical composition for oral administration
GB9418029D0 (en) Pharmaceutical compositions for oral administration
AU4491697A (en) Compositions of therapeutic agents suitable for oral administration